WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 10'8301 Infant (under 12 months) mortality rate: 122
GDP / capita (US$): 17'6511 Child (under 5 years) mortality rate: 152

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 73'997  73'059  72'138  71'241  70'364  63'174  53'995  43'906 
Births 1'268  1'275  1'282  1'288  1'295  1'356  1'407  1'551 
Surviving infants 1'253  1'259  1'264  1'269  1'274  1'315  1'316  1'385 
Pop. less than 5 years 6'362  6'363  6'359  6'366  6'370  6'571  6'648  6'641 
Pop. less than 15 years 19'249  19'261  19'262  19'278  19'283  19'364  19'575  17'588 
Female 15-49 years 20'075  19'859  19'647  19'442  19'243  17'275  13'675  10'403 

Number of reported case

(Click for retrospective incidence data for Turkey)
Diphtheria 20  86 
Japanese encephalitis
Measles 111  16'244  11'372  8'618 
Mumps 1'609  1'525  2'180  9'514 
Pertussis 242  48  11  17  510  454  1'520 
Polio* 24  182 
Rubella 1'734  64  97  139 
Rubella (CRS)
Tetanus (neonatal) 26  67 
Tetanus (total) 24  25  12  19  38  123  48 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Turkey)
Vaccine year result method % card seen                                                
BCG 2007  96  DHS   72.6  96  97  96  96  82  16  74 
DTP1 2007  97  DHS   72.6  98  98  97  97  92 
DTP3 2007  89  DHS   72.6  97  97  96  96  85  74  42 
HepB_BD          97  96 
HepB3 2007  86  DHS   72.6  96  96  94  92  71 
Hib3          97  97  96  96 
JapEnc         
MCV 2007  89  DHS   72.6  98  97  97  97  86  67  27 
MCV2          86  91  88  92 
PCV1          98 
PCV3          96  93 
Pol3 2007  89  DHS   72.6  97  97  96  96  85  74  63 
Rota1         
Rota_last         
Rubella1          98  97  97  97 
TT2plus 1997  29  DHS   38.5  57  51  57  56  36  18 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Turkey)
BCG 96  96  97  96  96  96  93 
DTP1 98  98  98  97  97  92  94  67 
DTP3 97  97  97  96  96  85  84  42 
HepB3 96  96  96  94  92  71 
Hib3 97  97  97  96  96 
MCV 98  98  97  97  97  87  78  27 
PAB 90  90  90  71  71  50  20 
PCV3 96  96  93 
Pol3 97  97  97  96  96  85  84  63 
Rota_last

Number of districts in the country 81  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 2 months; Yes
DTaPHibIPV 2, 4, 6, 18 months; Yes
DTaPIPV 6 years; Yes
HepB birth; 2, 6 months; Yes
MMR 12 months; 6 years; Yes
OPV 6, 18 months; Yes
Pneumo_conj 2, 4, 6, 12 months; Yes
Td 1st contact; +1, +6 months; +1, +1 years; Yes CBAW

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR   Yes  Yes  Yes  Yes  No  No 
What years does the MYP cover? number   5 years  2010-2014  2009-2013  2008-2013     
Nº of districts with microplans that include activities to raise immunization coverage number           81  81 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR   Yes  Yes         

System performance

Total number of districts in country number   81  81  81  81  81  81 
Nº districts with DTP3 coverage >=80% number   81  81  81  81  81  72 
% of districts with DTP3 coverage >=80% From 0 to 100%   100  100  100  100  100  89 
Nº districts with measles (MCV1) coverage >=95% number   73  70  65  50     
% of districts with MCV1 coverage >=95% From 0 to 100%   90  86  80  62     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR   Yes  Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND   Yes  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100%   100  100  100  100  100  100 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  No  No  No 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.